Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, ten Berg JM, Steg PG, Hohnloser SH, for the RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017;377:1513-24. [Ref.ID 102099]
2. Cita con resumen
Ellis SG, Kereiakes DJ, Metger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang ZS, Simonton C, Stone GW, for the ABSORB III Investigators. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 2015;373:1905-15. [Ref.ID 99671]
3.Tiene citas relacionadas Cita con resumen
Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann F-J, Effron MB, Barnathan ES, Topol EJ, for the FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-17. [Ref.ID 82953]
4.Tiene citas relacionadas
Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and placlitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. [Ref.ID 79499]
5.Tiene citas relacionadas
Stone GW, Popma JJ, Ellis SG. Paclitaxel-eluting stents, brachytherapy, and in-stent restenosis. In reply. JAMA 2006;296:1838-9. [Ref.ID 78356]
6.Tiene citas relacionadas
Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russesll ME, for the TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. The TAXUS V ISR randomized trial. JAMA 2006;295:1253-63. [Ref.ID 76527]
7.Tiene citas relacionadas
Stone GW, Ellis SG, Russell M E. Paclitaxel-eluting coronary stents. The authors reply. N Engl J Med 2004;350:2100. [Ref.ID 70042]
8. Cita con resumen
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma J J, Russell M E, for the TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. [Ref.ID 68729]
9.Tiene citas relacionadas Cita con resumen
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904. [Ref.ID 67183]
10.
Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ, for the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999;341:319-27. [Ref.ID 45737]
11. Cita con resumen
Topol EJ, Ferguson JJ, Weisman HF, Tcheng JE, Ellis SG, Kleiman NS, Ivanhoe R, Wang AL, Miller DP, Anderson KM, Califf RM, for the EPIC Investigator Group. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin ß3 blockade with percutaneous coronary intervention. JAMA 1997;278:479-84. [Ref.ID 34524]
12.
Topol EJ, Califf RM, Weissman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee K L, Willerson JT, on Behalf of the Epic Investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months*. Lancet 1994;343:881-6. [Ref.ID 21649]
13.Tiene citas relacionadas Cita con resumen
Topol EJ, Leya F, Pinkerton C A, Whitlow PL, Hofling B, Leon MB, Williams DO, King SB, Mark DB, Isner JM, Holmes DR, Ellis SG, Lee K L, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the Caveat Study Group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7. [Ref.ID 19672]
Seleccionar todas
 
 1 a 13 de 13